DSC Advisors L.P. purchased a new position in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 80,000 shares of the company’s stock, valued at approximately $2,244,000. Tabula Rasa HealthCare accounts for about 1.3% of DSC Advisors L.P.’s portfolio, making the stock its 18th biggest holding.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Stone Ridge Asset Management LLC acquired a new stake in Tabula Rasa HealthCare during the 4th quarter worth about $433,000. Deutsche Bank AG raised its stake in shares of Tabula Rasa HealthCare by 156.1% during the 4th quarter. Deutsche Bank AG now owns 21,293 shares of the company’s stock valued at $596,000 after buying an additional 12,978 shares during the last quarter. BlueCrest Capital Management Ltd purchased a new position in shares of Tabula Rasa HealthCare during the 4th quarter valued at about $237,000. Driehaus Capital Management LLC raised its stake in shares of Tabula Rasa HealthCare by 45.5% during the 4th quarter. Driehaus Capital Management LLC now owns 25,448 shares of the company’s stock valued at $714,000 after buying an additional 7,953 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new position in shares of Tabula Rasa HealthCare during the 4th quarter valued at about $2,432,000. 53.03% of the stock is owned by institutional investors.
In related news, CEO Calvin H. Knowlton sold 8,000 shares of Tabula Rasa HealthCare stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $32.75, for a total value of $262,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bruce Luehrs sold 3,115 shares of Tabula Rasa HealthCare stock in a transaction dated Tuesday, March 6th. The shares were sold at an average price of $36.03, for a total value of $112,233.45. The disclosure for this sale can be found here. In the last 90 days, insiders sold 295,021 shares of company stock valued at $10,167,309. 45.80% of the stock is owned by company insiders.
Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings results on Monday, March 12th. The company reported $0.09 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.12 by ($0.03). Tabula Rasa HealthCare had a net margin of 10.63% and a negative return on equity of 2.43%. The business had revenue of $43.93 million during the quarter, compared to analysts’ expectations of $38.91 million. During the same quarter in the prior year, the firm earned $0.10 EPS. Tabula Rasa HealthCare’s revenue for the quarter was up 60.9% on a year-over-year basis. analysts anticipate that Tabula Rasa HealthCare Inc will post 0.38 EPS for the current fiscal year.
A number of equities analysts have weighed in on the company. CIBC reiterated an “outperform” rating and set a $47.00 price objective (up previously from $35.00) on shares of Tabula Rasa HealthCare in a research note on Tuesday. William Blair reiterated an “outperform” rating on shares of Tabula Rasa HealthCare in a research note on Tuesday. Oppenheimer lifted their price objective on Tabula Rasa HealthCare from $35.00 to $47.00 and gave the company an “outperform” rating in a research note on Tuesday. Piper Jaffray Companies lifted their price objective on Tabula Rasa HealthCare to $43.00 and gave the company an “overweight” rating in a research note on Tuesday. Finally, Zacks Investment Research lowered Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Tabula Rasa HealthCare presently has an average rating of “Buy” and a consensus price target of $33.50.
WARNING: This article was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2018/03/14/80000-shares-in-tabula-rasa-healthcare-inc-trhc-purchased-by-dsc-advisors-l-p.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.